<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: A review of the pathophysiologic features of early type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, the benefits of early glycemic control, the concerns of patients that may influence treatment adherence, and how the use of newer treatment options are addressed </plain></SENT>
<SENT sid="1" pm="."><plain>CONCLUSION: Given the multifactorial nature of <z:mp ids='MP_0002055'>diabetes</z:mp> pathophysiology, early combination therapy incorporating agents with different mechanisms of action is advocated </plain></SENT>
<SENT sid="2" pm="."><plain>Medication side effects and risks influence patients' treatment choices </plain></SENT>
<SENT sid="3" pm="."><plain>These concerns include <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, <z:mp ids='MP_0005456'>weight gain</z:mp>, and fears of treatment failure </plain></SENT>
<SENT sid="4" pm="."><plain>With the increasing complexity of therapy regimens for <z:mp ids='MP_0002055'>diabetes</z:mp>, the role of <z:mp ids='MP_0002055'>diabetes</z:mp> educators includes recommending therapy, counseling about adverse effects, monitoring for contraindications, identifying therapeutic duplication, as well as discussion of new agents to optimize patient outcomes </plain></SENT>
<SENT sid="5" pm="."><plain>A case study is used to describe the process of choosing well-tolerated therapies at first diagnosis </plain></SENT>
</text></document>